Form 8-K - Current report:
SEC Accession No. 0001193125-24-097954
Filing Date
2024-04-16
Accepted
2024-04-16 17:28:05
Documents
18
Period of Report
2024-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d691589d8k.htm   iXBRL 8-K 35370
2 EX-10.1 d691589dex101.htm EX-10.1 58326
7 GRAPHIC g691589g0417005945694.jpg GRAPHIC 658
8 GRAPHIC g691589g0417005945944.jpg GRAPHIC 714
9 GRAPHIC g691589g0417005946196.jpg GRAPHIC 658
  Complete submission text file 0001193125-24-097954.txt   278950

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acab-20240410.xsd EX-101.SCH 3130
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acab-20240410_def.xml EX-101.DEF 14012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acab-20240410_lab.xml EX-101.LAB 23271
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acab-20240410_pre.xml EX-101.PRE 14850
22 EXTRACTED XBRL INSTANCE DOCUMENT d691589d8k_htm.xml XML 7216
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Atlantic Coastal Acquisition Corp. II (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 24848805
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)